Asian Pacific Journal of Allergy and Immunology

  • HOME
  • ABOUT
  • EDITORS
  • SUBMISSION
    • Online Submission
    • Author Instructions
  • ISSUE
    • Current
    • Early Online
    • Archives
  • PERMISSIONS
  • CONTACT
  • ADVERTISE
Home
 / 
nattiyap@gmail.com
 / 
nattiyap@gmail.com
 / 
Page 8
January 23, 2023

Allergen immunotherapy for respiratory allergies in clinical practice: A comprehensive review

Allergen-specific immunotherapy (AIT) is the only treatment that modifies the underlying pathophysiology of IgE-mediated allergic diseases.
read more
allergen, Allergic rhinitis, Allergy, Asthma, Immunotherapy
January 23, 2023

Did variants in inborn errors of immunity genes contribute to the extinction of Neanderthals?

Neanderthals were a species of archaic humans that became extinct around 40,000 years ago. Modern humans have inherited 1-6% of Neanderthal DNA as a result of interbreeding. These inherited Neanderthal genes have paradoxical influences, while some can provide protection to viral infections, some others are associated with autoimmune/auto-inflammatory diseases.
read more
Cytotoxicity, Denisovan, glycosylation, Hemophagocytic Lymphohistiocystosis (HLH), HLA, inborn errors of immunity (IEI), Innate immunity, MHC I presentation, MOGS, Neanderthals, UNC13D, viral infection
January 23, 2023

Binding and neutralizing antibody levels and vaccine efficacy/effectiveness compared between heterologous and homologous primary series COVID-19 vaccination: A systematic review and meta-analysis

The data on the immunogenicity and efficacy of heterologous primary series COVID-19 vaccination are still limited.
read more
Binding antibody, COVID-19 vaccination, heterologous primary series, homologous primary series, neutralizing antibody, systematic review and meta-analysis, vaccine efficacy/effectiveness
January 2, 2023

The validity and reliability of a Thai version of the Angioedema Control Test: Which recall period is preferable?

The Angioedema Control Test (AECT) is a questionnaire that monitors disease control in patients with angioedema, with a recall period of 4 weeks (AECT-4wk) or 3 months (AECT-3mo).
read more
4-week, Angioedema Control Test, Reliability, Screening accuracy, Validity
January 2, 2023

Humoral SARS-CoV-2 immunogenicity wanes 3 months after heterologous inactivated vaccine followed by ChAdOx1 nCoV-19 in autoimmune rheumatic diseases

Alongside vaccine hesitancy, impaired and waning immunity in autoimmune rheumatic diseases (ARDs) are barriers to immunization. The timeframe of immunity waning in ARD remains unclear.
read more
autoimmune rheumatic diseases, immunogenicity, immunosuppressive drugs, SAR-CoV2 vaccine, waning
January 2, 2023

COVID-19 Vaccine Allergy Safety Track (VAS-Track) pathway: real-world outcomes on vaccination rates and antibody protection

Misdiagnosed vaccine-related “allergies” lead to unnecessary vaccine deferrals and incomplete vaccinations, leaving patients unprotected against COVID-19. To overcome limitations and queues for Allergist assessment, the “VAS-Track” pathway was developed to evaluate patients via a multi-disciplinary triage model including nurses, non-specialists, and Allergists.
read more
Allergy, antibody, COVID-19, safety, vaccine
January 2, 2023

The association between MTHFR polymorphism, dietary methyl donors, and childhood asthma and atopy

Studies investigating the genetic association of the C677T methylenetetrahydrofolate reductase (MTHFR) genotype and dietary methyl donors with asthma and atopy are limited, and have variable results.
read more
Asthma, atopy, Folate, Methyl donors, MTHFR, polymorphism
December 29, 2022

Improving cytokine-induced killer cell expansion using a gas-permeable culture method for clinical-scale production

Cytokine-induced killer (CIK) cells are a heterogeneous group of immune cells that exert potent MHC-unrestricted cytotoxicity toward various cancer cells in both solid and hematological malignancies.
read more
acute myeloid leukemia, adoptive cellular therapy, clinical-scale expansion, Cytokine-induced killer cell, gas-permeable culture
October 25, 2022

NLRP12 attenuates tumor necrosis factor-α production in Burkholderia pseudomallei-infected RAW264.7 macrophages

NLRP12 has been shown to play an essential role as a negative regulator in several bacterial infection.
read more
Burkholderia pseudomallei, mouse macrophage, NLRP12, RAW264.7
October 25, 2022

Bosentan versus nifedipine in the treatment of vasculopathy in systemic sclerosis patients: A randomized control trial

Bosentan is effective agent in scleroderma vasculopathy. However, there are no studies evaluating effectiveness of bosentan in Vietnamese patients, where nifedipine is still the common treatment.
read more
bosentan, digital ulcers, pulmonary arterial hypertension, Raynaud, vasculopathy

Pages:

« 1 … 6 7 8 9 10 … 28 »

Categories

  • Announcement (1)
  • Case Report (23)
  • Early Online (93)
  • Original Article (223)
  • Review Article (29)

Key words

allergen Allergic rhinitis Allergy Anaphylaxis Asthma atopic dermatitis child Children Chlorhexidine chronic rhinosinusitis chronic spontaneous urticaria Chronic Urticaria COVID-19 cytokine depression diagnosis drug allergy Drug hypersensitivity efficacy Epidemiology food allergy Food hypersensitivity house dust mite IgE Immunotherapy obstructive sleep apnea Omalizumab prevalence primary immunodeficiency Quality of life Questionnaire Reliability risk factor risk factors safety SARS-CoV-2 Sensitization Severe asthma Skin prick test Specific IgE Thai treatment urticaria vaccine Vitamin D
Asian Pacific Journal of Allergy and Immunology

Support Contact

Managing Editor
Ms. Patrawadee Pitakpolrat
E-mail: managingeditor@apjai-journal.org

Production Editor
Ms. Chanita Jangsawang
E-mail: chanita.j@apjai-journal.org

Asian Pacific Journal of Allergy and Immunology © 2026 All rights reserved.
All rights reserved | Privacy Policy